400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2018-08-08
转化细胞疗法候选药物研发商
医药研发/制造
化学&生物药
Invus;
Invus;
JDRF T1D Fund;
JDRF T1D Fund;
Strawberry Creek Ventures;
Polaris Partners;
JMCR Partners;
Viva Ventures Biotech Group;
Illumina Ventures;
Total Access Fund;
NanoDimension
动脉网2026-03-12
动脉网2026-03-12
2026-03-11
动脉网2026-03-11
PR Newswire2026-03-11
PR Newswire2026-03-11
2026-03-11
动脉网2026-03-11
startupticker2026-03-11
GlobeNewswire2026-03-10